Koshinski Asset Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,267
| Closed | -$234M | – | 636 |
|
|
2024
Q4 | $234M | Buy |
1,267
+43
| +4% | +$7.94M | 0.02% | 556 |
|
|
2024
Q3 | $241K | Buy |
1,224
+41
| +3% | +$8.08K | 0.02% | 542 |
|
|
2024
Q2 | $239K | Buy |
1,183
+154
| +15% | +$31.1K | 0.02% | 515 |
|
|
2024
Q1 | $279K | Buy |
+1,029
| New | +$279K | 0.03% | 451 |
|
|
2023
Q4 | – | Sell |
-1,034
| Closed | -$203K | – | 524 |
|
|
2023
Q3 | $203K | Buy |
1,034
+2
| +0.2% | +$392 | 0.02% | 528 |
|
|
2023
Q2 | $217K | Sell |
1,032
-155
| -13% | -$32.6K | 0.02% | 539 |
|
|
2023
Q1 | $240K | Buy |
1,187
+24
| +2% | +$4.84K | 0.02% | 485 |
|
|
2022
Q4 | $253K | Sell |
1,163
-5
| -0.4% | -$1.09K | 0.02% | 500 |
|
|
2022
Q3 | $230K | Buy |
+1,168
| New | +$230K | 0.03% | 468 |
|
|
2022
Q2 | – | Sell |
-825
| Closed | -$234K | – | 843 |
|
|
2022
Q1 | $234K | Buy |
825
+194
| +31% | +$55.1K | 0.02% | 541 |
|
|
2021
Q4 | $238K | Buy |
631
+243
| +63% | +$91.6K | 0.02% | 571 |
|
|
2021
Q3 | $160K | Buy |
+388
| New | +$160K | 0.01% | 678 |
|